Si-Bone (SIBN) Property, Plant & Equipment (Net) Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 13.22% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 9.93% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 8.89% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 19.89% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 7.35% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 14.29% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 8.56% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 10.46% |
| 10 | Si-Bone | 611.92 Mn | 471.80 Mn | 41.94 Mn | -2.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.94% |
| Dec 31, 2025 | 4.54% |
| Sep 30, 2025 | 5.69% |
| Jun 30, 2025 | 13.57% |
| Mar 31, 2025 | 21.48% |
| Dec 31, 2024 | 27.34% |
| Sep 30, 2024 | 25.84% |
| Jun 30, 2024 | 8.70% |
| Mar 31, 2024 | 4.32% |
| Dec 31, 2023 | 2.80% |
| Sep 30, 2023 | 14.10% |
| Jun 30, 2023 | 37.23% |
| Mar 31, 2023 | 61.82% |
| Dec 31, 2022 | 73.09% |
| Sep 30, 2022 | 82.60% |
| Jun 30, 2022 | 62.81% |
| Mar 31, 2022 | 41.06% |
| Dec 31, 2021 | 98.63% |
| Sep 30, 2021 | 76.67% |
| Jun 30, 2021 | 78.53% |
| Mar 31, 2021 | 70.65% |
| Dec 31, 2020 | 14.49% |
| Sep 30, 2020 | 48.07% |
| Jun 30, 2020 | 74.05% |
| Mar 31, 2020 | 82.75% |
| Dec 31, 2019 | 83.57% |
| Sep 30, 2019 | 47.71% |
| Dec 31, 2018 | 13.61% |